Patterson Companies, Inc.
General ticker "PDCO" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $2.3B
Patterson Companies, Inc. does not follow the US Stock Market performance with the rate: -22.7%.
Estimated limits based on current volatility of 0.3%: low 30.79$, high 30.91$
Factors to consider:
- Company pays dividends: last record date 2024-10-18, amount 0.26$ (Y3.37%)
- US accounted for 83.8% of revenue in the fiscal year ended 2023-04-29
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-04-27 to 2026-04-27
- 2024-04-27 to 2025-04-27 estimated range: [21.98$, 34.57$]
- 2025-04-27 to 2026-04-27 estimated range: [21.98$, 34.65$]
Financial Metrics affecting the PDCO estimates:
- Positive: Non-GAAP EPS, $ of 2.31 > 2.29
- Negative: Operating cash flow per share per price, % of -24.41 <= 2.35
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 6.03
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0.48 <= 0.74
- Positive: 1.03 < Operating profit margin, % of 3.85
Short-term PDCO quotes
Long-term PDCO plot with estimates
Financial data
| YTD | 2022-04-30 | 2023-04-29 | 2024-04-27 |
|---|---|---|---|
| Operating Revenue | $6,499.40MM | $6,471.47MM | $6,568.27MM |
| Operating Expenses | $6,342.40MM | $6,195.50MM | $6,315.35MM |
| Operating Income | $157.00MM | $275.97MM | $252.92MM |
| Non-Operating Income | $109.25MM | $-5.81MM | $-9.87MM |
| Interest Expense | $20.29MM | $5.81MM | $44.91MM |
| R&D Expense | $7.27MM | $9.07MM | $0.00MM |
| Income(Loss) | $266.25MM | $270.16MM | $243.05MM |
| Taxes | $64.54MM | $63.56MM | $57.12MM |
| Profit(Loss) | $201.71MM | $206.60MM | $185.93MM |
| Stockholders Equity | $1,041.68MM | $1,117.54MM | $1,001.14MM |
| Inventory | $785.60MM | $795.07MM | $782.90MM |
| Assets | $2,741.63MM | $2,879.15MM | $2,896.73MM |
| Operating Cash Flow | $-980.99MM | $-754.85MM | $-789.38MM |
| Capital expenditure | $38.31MM | $64.22MM | $67.63MM |
| Investing Cash Flow | $1,239.03MM | $901.57MM | $959.54MM |
| Financing Cash Flow | $-253.23MM | $-126.48MM | $-215.91MM |
| Earnings Per Share* | $2.09 | $2.14 | $2.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.